Goldman Sachs’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-812,927
Closed -$2.47M 5330
2024
Q4
$2.47M Sell
812,927
-350,444
-30% -$1.07M ﹤0.01% 3336
2024
Q3
$6.04M Buy
1,163,371
+229,753
+25% +$1.19M ﹤0.01% 2624
2024
Q2
$2.4M Buy
933,618
+390,169
+72% +$1M ﹤0.01% 3093
2024
Q1
$2.67M Sell
543,449
-240,179
-31% -$1.18M ﹤0.01% 3017
2023
Q4
$6.89M Sell
783,628
-361,016
-32% -$3.17M ﹤0.01% 2356
2023
Q3
$13.1M Sell
1,144,644
-596,258
-34% -$6.84M ﹤0.01% 1798
2023
Q2
$44.1M Buy
1,740,902
+642,612
+59% +$16.3M 0.01% 1026
2023
Q1
$35.4M Sell
1,098,290
-113,570
-9% -$3.66M 0.01% 1122
2022
Q4
$22.4M Buy
1,211,860
+72,052
+6% +$1.33M 0.01% 1523
2022
Q3
$30.8M Buy
1,139,808
+310,883
+38% +$8.39M 0.01% 1281
2022
Q2
$11.5M Buy
828,925
+172,369
+26% +$2.38M ﹤0.01% 2020
2022
Q1
$12.8M Sell
656,556
-149,476
-19% -$2.91M ﹤0.01% 2038
2021
Q4
$13.2M Buy
806,032
+211,332
+36% +$3.45M ﹤0.01% 2069
2021
Q3
$16.6M Buy
594,700
+129,264
+28% +$3.6M ﹤0.01% 1890
2021
Q2
$13.8M Buy
465,436
+17,721
+4% +$525K ﹤0.01% 2011
2021
Q1
$12.5M Buy
447,715
+43,589
+11% +$1.22M ﹤0.01% 2041
2020
Q4
$11.5M Sell
404,126
-48,490
-11% -$1.37M ﹤0.01% 1967
2020
Q3
$11.4M Sell
452,616
-108,259
-19% -$2.72M ﹤0.01% 1853
2020
Q2
$13.7M Sell
560,875
-170,659
-23% -$4.17M ﹤0.01% 1737
2020
Q1
$10.8M Buy
731,534
+623,626
+578% +$9.23M ﹤0.01% 1765
2019
Q4
$1.75M Buy
107,908
+33,193
+44% +$539K ﹤0.01% 3014
2019
Q3
$971K Buy
74,715
+21,030
+39% +$273K ﹤0.01% 3266
2019
Q2
$696K Sell
53,685
-58,773
-52% -$762K ﹤0.01% 3381
2019
Q1
$1.77M Buy
112,458
+72,996
+185% +$1.15M ﹤0.01% 3002
2018
Q4
$794K Sell
39,462
-43,908
-53% -$883K ﹤0.01% 3231
2018
Q3
$2.07M Sell
83,370
-52,872
-39% -$1.31M ﹤0.01% 2862
2018
Q2
$3.74M Buy
136,242
+77,221
+131% +$2.12M ﹤0.01% 2561
2018
Q1
$1.82M Buy
59,021
+32,475
+122% +$1M ﹤0.01% 2925
2017
Q4
$949K Sell
26,546
-158,334
-86% -$5.66M ﹤0.01% 3177
2017
Q3
$5.09M Buy
184,880
+5,223
+3% +$144K ﹤0.01% 2339
2017
Q2
$4.74M Sell
179,657
-368,993
-67% -$9.74M ﹤0.01% 2310
2017
Q1
$11.4M Buy
548,650
+141,400
+35% +$2.94M ﹤0.01% 1791
2016
Q4
$8.43M Sell
407,250
-18,375
-4% -$380K ﹤0.01% 1892
2016
Q3
$6.9M Buy
425,625
+446
+0.1% +$7.23K ﹤0.01% 2048
2016
Q2
$5.78M Buy
425,179
+125,123
+42% +$1.7M ﹤0.01% 2046
2016
Q1
$5.24M Sell
300,056
-15,770
-5% -$275K ﹤0.01% 2044
2015
Q4
$10.8M Sell
315,826
-65,659
-17% -$2.24M ﹤0.01% 1645
2015
Q3
$11.4M Buy
381,485
+71,547
+23% +$2.13M ﹤0.01% 1579
2015
Q2
$9.91M Sell
309,938
-106,027
-25% -$3.39M ﹤0.01% 1696
2015
Q1
$8.62M Buy
415,965
+13,210
+3% +$274K ﹤0.01% 1746
2014
Q4
$6.82M Sell
402,755
-22,690
-5% -$384K ﹤0.01% 1800
2014
Q3
$8.22M Sell
425,445
-14,257
-3% -$276K ﹤0.01% 1705
2014
Q2
$15M Buy
439,702
+196,599
+81% +$6.68M ﹤0.01% 1414
2014
Q1
$7.66M Buy
+243,103
New +$7.66M ﹤0.01% 1729